Search



Search only items with full text availability
Current filters:


Clear current filters  or Add more filters

View Option



Results 31-40 of 137 (Search time: 0.005 seconds).

  Is the expression of multidrug resistance gene product a prognostic indicator for the clinical outcome of patients with renal cancer? (Journal article)

  Paclitaxel (175 mg/m2) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6 AUC) in advanced non-small-cell lung cancer (NSCLC): a multicenter randomized trial. Hellenic Cooperative Oncology Group (HeCOG) (Journal article)

  Immune-mediated skin lesions in patients treated with anti-tumour necrosis factor alpha inhibitors (Journal article)

  Immediate post-operative effects of tracheotomy on respiratory function during mechanical ventilation (Journal article)

  Paclitaxel by 3-h infusion and carboplatin in anthracycline-resistant advanced breast cancer. A phase II study conducted by the Hellenic Cooperative Oncology Group (Journal article)

  Open type IIIB and IIIC fractures treated by an orthopaedic microsurgical team (Journal article)

  Patient's age modifies the impact of the proposed predictors of sustained virological response in chronic hepatitis C patients treated with PEG-interferon plus ribavirin (Journal article)

  Paclitaxel, cisplatin, leucovorin, and continuous infusion fluorouracil followed by concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the head and neck: a Hellenic Cooperative Oncology Group Phase II Study (Journal article)

  Outcome of patients with congestive heart failure treated with standard versus high doses of enalapril: a multicenter study. High Enalapril Dose Study Group (Journal article)

  Intensive chemotherapy with high-dose epirubicin every 2 weeks and prophylactic administration of filgrastim in advanced breast cancer (Journal article)